The rating affirmation was supported by a number of factors, including the system’s solid market position, its history of strong financial performance and strengthening balance sheet metrics.
ProHealth also faces some challenges, which were considered for the rating affirmation and the outlook revision, such as being highly leveraged and experience weak revenue growth over the last two years.
According to Moody’s, the outlook revision to negative reflects pressure on the system to rebuild momentum after two years of softening in order to generate ample cash-flow to cover the system’s high and rising debt load.
More articles on healthcare finance:
Moody’s assigns ‘A2’ rating to $13.5M of Hendrick Medical Center’s bonds
IASIS Healthcare’s revenue up 16.4% in Q4
50 things to know about Medicaid expansion
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
